RecruitingNot ApplicableNCT06685523

Evaluation of Fractalkine and Its Receptor in Peri-implantitis

Evaluation of Fractalkine and Its Receptor in the Non-Surgical Treatment of Peri-implantitis


Sponsor

Kubilay BARIŞ

Enrollment

100 participants

Start Date

Nov 8, 2024

Study Type

INTERVENTIONAL

Conditions

Summary

In this study, mechanical debridement group, Er:YAG laser group and diode laser group will be compared in terms of reducing peri-implant sulcus depth in the treatment of peri-implantitis.


Eligibility

Min Age: 40 YearsMax Age: 60 Years

Inclusion Criteria7

  • Probing depth of 4-6 mm, bone loss of at least 2 mm on X-ray and presence of inflammatory symptoms in soft tissue
  • No systemic disease that may affect the outcome of the treatment
  • Patients with healthy periodontium or patients with completed periodontal treatment
  • Individuals at least 6 months after prosthesis loading on the implant
  • Individuals who do not require further surgery for the treatment of peri-implantitis
  • Implants with at least 2 mm keratised gingiva
  • Individuals aged 40-60 years

Exclusion Criteria5

  • Individuals undergoing radiation therapy
  • Individuals who smoke and drink alcohol
  • Individuals in pregnancy or lactation
  • Individuals who have received antibiotic treatment in the last three months
  • Individuals with parafunctional habits

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

PROCEDURESubgingival debridement

To be applied 1 times (0. days)

PROCEDUREEr:YAG laser decontamination

To be applied 3 times

PROCEDUREDiyot laser decontamination

To be applied 3 times


Locations(1)

Kırıkkale University, Faculty of Dentistry, Department of Periodontology

Kırıkkale, Turkey (Türkiye)

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06685523


Related Trials